LIF is a contraction-induced myokine stimulating human myocyte proliferation.

The cytokine leukemia inhibitory factor (LIF) is expressed by skeletal muscle and induces proliferation of myoblasts. We hypothesized that LIF is a contraction-induced myokine functioning in an autocrine fashion to activate gene regulation of human muscle satellite cell proliferation. Skeletal muscle LIF expression, regulation, and action were examined in two models: 1) young men performing a bout of heavy resistance exercise of the quadriceps muscle and 2) cultured primary human satellite cells. Resistance exercise induced a ninefold increase in LIF mRNA content in skeletal muscle, but LIF was not detectable in plasma of the subjects. However, electrically stimulated cultured human myotubes produced and secreted LIF, suggesting that LIF is a myokine with local effects. The well established exercise-induced signaling molecules PI3K, Akt, and mTor contributed to the regulation of LIF in cultured human myotubes as chemical inhibition of PI3K and mTor and siRNA knockdown of Akt1 were independently sufficient to downregulate LIF. Human myoblast proliferation was increased by recombinant exogenous LIF and decreased by siRNA knockdown of the endogenous LIF receptor. Finally, the transcription factors JunB and c-Myc, which promote myoblast proliferation, were induced by LIF in cultured human myotubes. Indeed, both JunB and c-Myc were also increased in skeletal muscle following resistance exercise. Our data suggest that LIF is a contraction-induced myokine, potentially acting in an autocrine or paracrine fashion to promote satellite cell proliferation.

[1]  Michael J. Short,et al.  Early time course of Akt phosphorylation after endurance and resistance exercise. , 2010, Medicine and science in sports and exercise.

[2]  B. Blagoev,et al.  Dynamics of the Skeletal Muscle Secretome during Myoblast Differentiation* , 2010, Molecular & Cellular Proteomics.

[3]  S. Fujita,et al.  Resistance exercise increases leg muscle protein synthesis and mTOR signalling independent of sex , 2010, Acta physiologica.

[4]  B. Pedersen,et al.  ROS and myokines promote muscle adaptation to exercise , 2009, Trends in Endocrinology & Metabolism.

[5]  Bertrand Guillotin,et al.  Three LIF-dependent signatures and gene clusters with atypical expression profiles, identified by transcriptome studies in mouse ES cells and early derivatives , 2009, BMC Genomics.

[6]  M. Febbraio,et al.  Muscle as an endocrine organ: focus on muscle-derived interleukin-6. , 2008, Physiological reviews.

[7]  B. Pedersen,et al.  Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle , 2008, The Journal of physiology.

[8]  P. Muñoz-Cánoves,et al.  Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. , 2008, Cell metabolism.

[9]  Zhenguo Wu,et al.  JAK1–STAT1–STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts , 2007, The Journal of cell biology.

[10]  B. Pedersen,et al.  Role of myokines in exercise and metabolism. , 2007, Journal of applied physiology.

[11]  K. Esser,et al.  Last Word on Point:Counterpoint: Satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. , 2007, Journal of applied physiology.

[12]  C. Lang,et al.  Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. , 2007, Journal of applied physiology.

[13]  F. Booth,et al.  Leukemia inhibitory factor restores the hypertrophic response to increased loading in the LIF(-/-) mouse. , 2006, Cytokine.

[14]  J. Babraj,et al.  Anabolic signaling and protein synthesis in human skeletal muscle after dynamic shortening or lengthening exercise. , 2006, American journal of physiology. Endocrinology and metabolism.

[15]  T. Rando,et al.  Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. , 2005, Trends in cell biology.

[16]  Joonhee Kim,et al.  Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. , 2005, Biochimica et biophysica acta.

[17]  D. Theisen,et al.  Regulation of mTOR by amino acids and resistance exercise in skeletal muscle , 2005, European Journal of Applied Physiology.

[18]  Donald E Mager,et al.  Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep , 2004, Journal of Pharmacology and Experimental Therapeutics.

[19]  F. Booth,et al.  Control of the size of the human muscle mass. , 2004, Annual review of physiology.

[20]  A. Kawasaki,et al.  Reciprocal Inhibition between MyoD and STAT3 in the Regulation of Growth and Differentiation of Myoblasts* , 2003, Journal of Biological Chemistry.

[21]  D. Williamson,et al.  Immediate Response of Mammalian Target of Rapamycin (mTOR)‐Mediated Signalling Following Acute Resistance Exercise in Rat Skeletal Muscle , 2003, The Journal of physiology.

[22]  N. LeBrasseur,et al.  Differential activation of mTOR signaling by contractile activity in skeletal muscle. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  D. Metcalf The Unsolved Enigmas of Leukemia Inhibitory Factor , 2003, Stem cells.

[24]  F. Booth,et al.  Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. , 2002, American journal of physiology. Cell physiology.

[25]  G. Lynch,et al.  Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol , 2002, Muscle & nerve.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[28]  J. Bower,et al.  Leukemia inhibitory factor enhances regeneration in skeletal muscles after myoblast transplantation , 2001, Muscle & nerve.

[29]  P. Neufer,et al.  Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. , 2000, American journal of physiology. Endocrinology and metabolism.

[30]  E. Senba,et al.  Gene Expression of Receptors for IL-6, LIF, and CNTF in Regenerating Skeletal Muscles , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  M. Sano,et al.  Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles. , 2000, Biochimica et biophysica acta.

[32]  E. Senba,et al.  Localization of leukemia inhibitory factor and interleukin‐6 messenger ribonucleic acids in regenerating rat skeletal muscle , 1998, Muscle & nerve.

[33]  J. L. Rosa,et al.  JunB Is Involved in the Inhibition of Myogenic Differentiation by Bone Morphogenetic Protein-2* , 1998, The Journal of Biological Chemistry.

[34]  B. Wold,et al.  c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation , 1991, Molecular and cellular biology.

[35]  A. Burgess,et al.  Stimulation of myoblast proliferation in culture by leukaemia inhibitory factor and other cytokines , 1991, Journal of the Neurological Sciences.

[36]  J. Bergstrom Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. , 1975, Scandinavian journal of clinical and laboratory investigation.